Thomas, David R.
GlaxoSmithKline plc.,
United Kingdom
2025 Rank: 239644
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2364 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 239644 | 270641 |
| Total Cites | 2890 | 3102 |
| H-index | 29 | 29 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 80 | 80 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 1017 | 1087 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 1798 | 1910 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2014 | 2115 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.47 |
| Self-Citation Percentage |
6.83%
|
|
Thomas, David R.
GlaxoSmithKline plc.,
United Kingdom
2024 Rank: 226429
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2235 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 226429 | 256074 |
| Total Cites | 2848 | 3060 |
| H-index | 29 | 29 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 74 | 74 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 996 | 1066 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 1768 | 1880 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1974 | 2075 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.47 |
| Self-Citation Percentage |
6.93%
|
|
Thomas, David R.
GlaxoSmithKline plc.,
United Kingdom
2023 Rank: 214295
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2165 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 214295 | 239439 |
| Total Cites | 2810 | 3021 |
| H-index | 28 | 29 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 72 | 72 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 982 | 1052 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 1744 | 1856 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1945 | 2045 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.48 |
| Self-Citation Percentage |
6.98%
|
|
Thomas, David R.
GlaxoSmithKline plc.,
United Kingdom
2022 Rank: 198068
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 2009 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 198068 | 222019 |
| Total Cites | 2752 | 2964 |
| H-index | 28 | 29 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 67 | 67 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 958 | 1028 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 1709 | 1821 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1900 | 2001 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.48 |
| Self-Citation Percentage |
7.15%
|
|
Thomas, David R.
GlaxoSmithKline plc.,
United Kingdom
2021 Rank: 189850
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1950 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 189850 | 215892 |
| Total Cites | 2703 | 2915 |
| H-index | 28 | 28 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 64 | 64 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 943 | 1013 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 1681 | 1793 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1864 | 1965 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.48 |
| Self-Citation Percentage |
7.27%
|
|
Thomas, David R.
GlaxoSmithKline plc.,
United Kingdom
2020 Rank: 175373
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1702 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 175373 | 196604 |
| Total Cites | 2623 | 2834 |
| H-index | 27 | 28 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 60 | 60 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 921 | 991 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 1641 | 1753 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1805 | 1905 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.49 |
| Self-Citation Percentage |
7.45%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.